Discover pharma promotional spend in 2016

Why multichannel is vital to Europe, why it is lagging and what can be done about it ? How does Belgium compare ?

Discover pharma promotional spend in 2016



11h30: welcome

12h00-13h00 : conferences

13h00-14h00 : walking lunch

Onderwerp(en) van de dag

12h00  - 12h30  :  Why multichannel is vital to Europe, why it is lagging and what can be done about it ?

Spreker : Christopher Wooden, Vice-President Global Sales Channel Dynamics, IMS Health

Christopher Wooden began working in health care over 25 years ago driving ambulance in New York City. Since then he has held various marketing and senior management roles in industry and on the research agency side - including international development of the CAM and Cegedim global promotion audits. Now based in Paris, France, Christopher joined the Information Offerings team in 2015 and leads ChannelDynamics™ - the global sales force and marketing channel performance measurement service of IMS Health. Christopher is a long-time member of the EphMRA Data and Systems Committee and a Senior Associate member of the Royal Society of Medicine. Christopher studied linguistics and advertising at the State University of New York, Binghamton and International Marketing at The American University in Paris, France.


12h30  - 13h00  :  Discover pharma promotional spend in 2016

Spreker : Carlo Ciapparelli, General Manager Northern Europe , IMS Health Belgium

Carlo is General Manager BeNeLux and Nordics at IMS Health. He has over 17 years of extensive experience in the pharmaceutical and consulting industry in Europe. Prior to joining IMS in 1999, Carlo spent a number of years in pharmaceutical consulting gaining extensive experience in pricing & reimbursement and the application of health economics in regulatory submissions. Since then, he has worked in a number of roles including head of the IMS forecasting team. In this capacity, he led in-depth strategic research addressing economic and political trends, pricing, reimbursement and regulatory issues, and the business environment in major pharmaceutical markets. He has also worked as Principal Thought Leadership with a focus on developing customer engagements showcasing new insights on current issues in the industry and completing extensive research on the impact of increasing cost containment measures in Europe, evaluating the effect of macro-economic factors on local healthcare infrastructures and business environments, leading to strategic recommendations for industry leaders. He has also worked as Principal Commercial Effectiveness Services covering Belgium, Netherlands, Nordics and Baltic countries with strong expertise covering the design, management and implementation of various commercial effectiveness solutions.

Carlo holds a degree in Biology from the Università Statale of Milan (Italy) and a master in journalism from the Università of Ferrara (Italy).



Identificeer u om toegang te krijgen tot de presentaties van dit event.

Through their support to the CIB, the members actively contribute to the development of valuable data for the industry.
This is why the CIB recommends especially these confirmed competence providers and we bet that they will prove worthy of your trust.

We gebruiken cookies om websiteverkeer te analyseren en uw surfcomfort te optimaliseren